A Phase II Double-Blind Randomized Study of the Simultaneous Administration of Recombinant Human Interleukin-6 and Recombinant Human Granulocyte Colony-Stimulating Factor Following Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

Author： Hochster H.   Speyer J.L.   Mandeli J.P.   Runowicz C.   Wadler S.   Berk G.   Wallach R.   Holland J.F.   for the New York Gynecologic Oncology Group  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.72, Iss.3, 1999-03, pp. : 292-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

By Mori K.   Hirose T.   Machida S.   Yokoyama K.   Tominaga K.  

European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. : 503-505

Elsevier

Access to resources Recommend Favorite

A Single-blind, Randomised, Vehicle-controlled Dose-finding Study of Recombinant Human Granulocyte Colony-stimulating Factor (Lenograstim) in Patients Undergoing Chemotherapy for Solid Cancers and Lymphoma

By Seymour A.-M.   de Campos E.   Thatcher N.   De Greve J.   Cunningham D.   Howell A.   Tueni E.   Bron D.G.   Steward W.P.   Berdel W.E.   Knuth A.   Lorenz J.   Timothy A.R.   Yver A.   Richards M.A.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2157-2163

Elsevier

Access to resources Recommend Favorite

An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in paediatric patients with metastatic neuroblastoma

By Michon J.M.   Hartmann O.   Bouffet E.   Meresse V.   Coze C.   Rubie H.   Bordigoni P.   Cattiaux E.   Ward N.   Bernard J.-L.   Lemerle J.   Zucker J.-M.   Philip T.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1063-1069

Elsevier

Access to resources Recommend Favorite

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study

By Schuler M.   Bruntsch U.   Spath-Schwalbe E.   Schrezenmeier H.   Peschel C.   Farber L.   Burger K.J.   Leiszner J.   Huber C.   Aulitzky W.E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 754-756

Elsevier

Access to resources Recommend Favorite